Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06559579
Status:
COMPLETED
Last Update Posted:
None
First Post:
2023-08-03
Brief Title:
Monoclonal Gammopathy With Clinical Significance in Patients With and Without Haematological Malignancies in Finistère Between 2012 and 2017 GammaClinik
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Comparative Study of Clinical Disorders Related to Monoclonal Gammopathy in Patients With Haematological Malignancies in Two Hospitals in Finistère Between 2012 and 2017 GammaClinik
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
GammaClinik
Brief Summary:
Clinical symptoms associated with monoclonal gammapathy have been primarily studied in hematological malignancy and rarely in MGUS and hemopathy Indeed most studies focus on a specific type of clinical involvement that does not allow to understand the epidemiological distribution of clinical symptoms in this population In addition in most cases studies of clinical impairment of monoclonal gammapathies focus on one symptom This study could highlight disparities in the representation of clinical disorders associated with monoclonal gammapathies depending on whether they are or not associated with a malignant hematology and would provide a better overall picture of the distribution of these diseases This study could potentially define prognosis values for certain clinical conditions that we would not find in the group of hematological malignancies This study would also make it possible to investigate whether there are clinical disorders of monoclonal gammapathies associated with chronic lymphomalymphocytic leukemia This would potentially guide future pathophysiological research This bicentric study could depending on the results be supplemented later by a larger study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None